Inger von Bültzingslöwen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Inger von Bültzingslöwen has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Michael T. Brennan
Department of Oral Medicine/Oral and Maxillofacial Surgery, Wake Forest University School of Medicine, Charlotte, USA
11 shared publications - Bengt Hasséus
Department of Oral Medicine and Pathology, Institute of Odontology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
7 shared publications - Nicole M. A. Blijlevens
Department of Hematology, Radboud University Medical Centre, Nijmegen, The Netherlands
7 shared publications - Alexa M. G. A. Laheij
Department of Oral Medicine, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and VU Amsterdam, Amsterdam, The Netherlands
6 shared publications - Judith E. Raber-Durlacher
Department of Oral Medicine, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and VU Amsterdam, Amsterdam, The Netherlands
6 shared publications - Marie-Charlotte D. N. J. M. Huysmans
Department of Dentistry, Radboud university medical center, Nijmegen, The Netherlands
6 shared publications
Latest Publications
- Open Access
- 2 October 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (10) , 1044
Association between oral ulcerative lesions, oral infections, and fever during the pre-engraftment phase after hematopoietic cell transplantation: results from the Orastem study
Purpose: The percentage of cases with fever of unknown origin after hematopoietic cell transplantation (HCT) is high. An often overlooked clinical infection in HCT recipients may be chronic inflammation from the oral cavity. Therefore, the aim of the present study was to assess fever in the pre-engraftment phase after HCT and to examine the relationship between oral foci of infection before and in the first weeks after HCT and fever. Methods: Adult patients, scheduled for autologous or allogeneic HCT, were included in this prospective, observational multicenter cohort study. Oral health was determined pre-HCT. Following HCT conditioning, fever was registered daily; and oral mucositis and other oral side effects were registered three times weekly. Results: Data from 186 patients were available. The mean age was 53.0 years (± 12.9), and 55.4% were male. The most common malignancies were multiple myeloma, acute myeloid leukemia, and lymphoma. In total, 69.4% of the patients developed fever and 43.1% had an oral ulcerative lesion. After correction for age, site, conditioning regimen, diarrhea, vomiting, and duration of leukopenia, oral ulceration size remained significantly associated with fever, especially when fever was defined as ≥ 38.5°C. Pre-HCT chronic dental and oral conditions showed no association with post-HCT fever. Conclusion: Fever was common during the pre-engraftment phase after HCT and significantly associated with the extent of oral ulcerations. In contrast, pre-HCT dental and oral conditions showed no association with post-HCT fever, highlighting the specific role of mucosal injury in febrile episodes.
- 2 October 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (10) , 1044
Open AccessAssociation between oral ulcerative lesions, oral infections, and fever during the pre-engraftment phase after hematopoietic cell transplantation: results from the Orastem study
Purpose: The percentage of cases with fever of unknown origin after hematopoietic cell transplantation (HCT) is high. An often overlooked clinical infection in HCT recipients may be chronic inflammation from the oral cavity. Therefore, the aim of the present study was to assess fever in the pre-engraftment phase after HCT and to examine the relationship between oral foci of infection before and in the first weeks after HCT and fever. Methods: Adult patients, scheduled for autologous or allogeneic HCT, were included in this prospective, observational multicenter cohort study. Oral health was determined pre-HCT. Following HCT conditioning, fever was registered daily; and oral mucositis and other oral side effects were registered three times weekly. Results: Data from 186 patients were available. The mean age was 53.0 years (± 12.9), and 55.4% were male. The most common malignancies were multiple myeloma, acute myeloid leukemia, and lymphoma. In total, 69.4% of the patients developed fever and 43.1% had an oral ulcerative lesion. After correction for age, site, conditioning regimen, diarrhea, vomiting, and duration of leukopenia, oral ulceration size remained significantly associated with fever, especially when fever was defined as ≥ 38.5°C. Pre-HCT chronic dental and oral conditions showed no association with post-HCT fever. Conclusion: Fever was common during the pre-engraftment phase after HCT and significantly associated with the extent of oral ulcerations. In contrast, pre-HCT dental and oral conditions showed no association with post-HCT fever, highlighting the specific role of mucosal injury in febrile episodes.
- Open Access
- 12 August 2026
- Published by Springer Nature in European Archives of Paediatric Dentistry
- p. 1-9
Oral disease burden in children and adolescents scheduled for allogeneic haematopoietic stem cell transplantation: a multicentre study
Purpose: Haematopoietic stem cell transplantation (HSCT) is a curative treatment for haematological malignancies and non-malignant haematological and immunological disorders. The oral cavity, which serves as a reservoir for infection, poses additional risks for patients undergoing HSCT. This study aimed to assess the oral disease burden among children and adolescents undergoing allogeneic HSCT (aHSCT) and to evaluate the oral healthcare they received before transplantation. Methods: This prospective, longitudinal, multicentre cohort study included 91 children and adolescents under 18 years of age who were scheduled for an aHSCT. Results: The mean age of the cohort was 11.2 ± 4.6 years, with acute leukaemia the most common diagnosis (47%), followed by non-malignant haematological disorders (15%). The prevalence of patient-reported oral symptoms was 49%, with sensitivity to hot and cold (10%) and loose teeth (7%) the most common complaints. Dental caries was present in 37%, and 13% had visible dental plaque on more than half of their teeth. Dental extractions were performed in 24% of patients, and 22% received dental restorations. Conclusion: Children and adolescents scheduled for aHSCT face a significant burden of oral disease, with notable dental issues that must be addressed before transplantation. This study underscores the importance of pre-transplant dental evaluations to address remaining dental concerns and minimise post-transplant complications.
- 12 August 2026
- Published by Springer Nature in European Archives of Paediatric Dentistry
- p. 1-9
Open AccessOral disease burden in children and adolescents scheduled for allogeneic haematopoietic stem cell transplantation: a multicentre study
Purpose: Haematopoietic stem cell transplantation (HSCT) is a curative treatment for haematological malignancies and non-malignant haematological and immunological disorders. The oral cavity, which serves as a reservoir for infection, poses additional risks for patients undergoing HSCT. This study aimed to assess the oral disease burden among children and adolescents undergoing allogeneic HSCT (aHSCT) and to evaluate the oral healthcare they received before transplantation. Methods: This prospective, longitudinal, multicentre cohort study included 91 children and adolescents under 18 years of age who were scheduled for an aHSCT. Results: The mean age of the cohort was 11.2 ± 4.6 years, with acute leukaemia the most common diagnosis (47%), followed by non-malignant haematological disorders (15%). The prevalence of patient-reported oral symptoms was 49%, with sensitivity to hot and cold (10%) and loose teeth (7%) the most common complaints. Dental caries was present in 37%, and 13% had visible dental plaque on more than half of their teeth. Dental extractions were performed in 24% of patients, and 22% received dental restorations. Conclusion: Children and adolescents scheduled for aHSCT face a significant burden of oral disease, with notable dental issues that must be addressed before transplantation. This study underscores the importance of pre-transplant dental evaluations to address remaining dental concerns and minimise post-transplant complications.
- Open Access
- 3 June 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (6) , 605
Longitudinal assessment and predictors of subjective taste change after hematopoietic cell transplantation (HCT)
Purpose: The aims of this investigation within the Orastem study were to describe the prevalence of subjective taste change, levels of patient-reported distress associated with taste change, and factors predicting taste change after hematopoietic cell transplantation (HCT) with a particular focus on factors predictive of severe and/or persistent (present at 12 months) taste change. Methods: Altogether, 238 patients at five cancer centers were followed during HCT hospitalization and up to 12 months post-HCT. Patients with taste change were compared to non-affected patients with respect to gender, age, transplant type, previous chemotherapy, conditioning regimen(s), oral mucositis, pre-HCT salivary flow, oral hygiene status and, in allogeneic HCT recipients, chronic oral graft-versus-host disease (GVHD). Distress from taste change was also evaluated. Results: During hospitalization, taste change was reported by over one-third (81/238) of patients to an open question on oral symptoms; of these, 41% reported taste change as their worst/most bothersome oral symptom. To a specific question on distress due to taste change, 76% of all patients reported some level of distress. Taste change from previous chemotherapy and full intensity conditioning were risk factors for severe taste change during hospitalization. At three months, allogeneic transplant patients reported a higher rate of severe taste change compared to autologous transplant patients. Increased age predicted severe taste change at 6 and 12-month follow-up. At twelve months, 13.1% of patients reported distress from taste change. Conclusion: This study confirmed taste change as a common clinical complaint post-HCT. Taste change remained a significant issue for a small subset of patients at 12 months. Further research is required to develop effective preventive and management strategies for this common oral side-effect post-HCT.
- 3 June 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (6) , 605
Open AccessLongitudinal assessment and predictors of subjective taste change after hematopoietic cell transplantation (HCT)
Purpose: The aims of this investigation within the Orastem study were to describe the prevalence of subjective taste change, levels of patient-reported distress associated with taste change, and factors predicting taste change after hematopoietic cell transplantation (HCT) with a particular focus on factors predictive of severe and/or persistent (present at 12 months) taste change. Methods: Altogether, 238 patients at five cancer centers were followed during HCT hospitalization and up to 12 months post-HCT. Patients with taste change were compared to non-affected patients with respect to gender, age, transplant type, previous chemotherapy, conditioning regimen(s), oral mucositis, pre-HCT salivary flow, oral hygiene status and, in allogeneic HCT recipients, chronic oral graft-versus-host disease (GVHD). Distress from taste change was also evaluated. Results: During hospitalization, taste change was reported by over one-third (81/238) of patients to an open question on oral symptoms; of these, 41% reported taste change as their worst/most bothersome oral symptom. To a specific question on distress due to taste change, 76% of all patients reported some level of distress. Taste change from previous chemotherapy and full intensity conditioning were risk factors for severe taste change during hospitalization. At three months, allogeneic transplant patients reported a higher rate of severe taste change compared to autologous transplant patients. Increased age predicted severe taste change at 6 and 12-month follow-up. At twelve months, 13.1% of patients reported distress from taste change. Conclusion: This study confirmed taste change as a common clinical complaint post-HCT. Taste change remained a significant issue for a small subset of patients at 12 months. Further research is required to develop effective preventive and management strategies for this common oral side-effect post-HCT.
- Open Access
- 24 October 2025
- Published by Springer Nature in Research Square
Oral disease burden in children and adolescents scheduled for allogeneic hematopoietic stem cell transplantation – a multicenter study
Purpose Hematopoietic stem cell transplantation (HSCT) is a curative treatment for various hematologic and non-hematologic disorders. The oral cavity, acting as a reservoir for infections, poses additional risks for patients undergoing HSCT. This study aimed to assess the burden of oral disease in children and adolescents preparing for allogeneic (a)HSCT and to evaluate the oral healthcare received before transplantation. Methods This prospective, longitudinal, multicentre cohort study included 91 children and adolescents under 18 years old scheduled for an aHSCT. Results The mean age of the cohort was 11.2 ± 4.6 years, with the most common diagnosis being acute leukaemia (47%), followed by non-malignant haematological disorders (15%). The prevalence of patient-reported oral symptoms was 49%, with sensitivity to hot and cold temperatures (10%) and loose teeth (7%) being the most common complaints. Dental caries was present in 37%, and 13% had visible dental plaque on more than half of their teeth. Dental extractions were performed in 24% of patients, and 22% received dental restorations. Conclusion Children and adolescents scheduled for aHSCT face a significant burden of oral disease, with notable dental issues that must be addressed before transplantation. This study highlights the importance of pre-transplant dental evaluations in addressing remaining dental concerns and minimizing post-transplant complications.
- 24 October 2025
- Published by Springer Nature in Research Square
Open AccessOral disease burden in children and adolescents scheduled for allogeneic hematopoietic stem cell transplantation – a multicenter study
Purpose Hematopoietic stem cell transplantation (HSCT) is a curative treatment for various hematologic and non-hematologic disorders. The oral cavity, acting as a reservoir for infections, poses additional risks for patients undergoing HSCT. This study aimed to assess the burden of oral disease in children and adolescents preparing for allogeneic (a)HSCT and to evaluate the oral healthcare received before transplantation. Methods This prospective, longitudinal, multicentre cohort study included 91 children and adolescents under 18 years old scheduled for an aHSCT. Results The mean age of the cohort was 11.2 ± 4.6 years, with the most common diagnosis being acute leukaemia (47%), followed by non-malignant haematological disorders (15%). The prevalence of patient-reported oral symptoms was 49%, with sensitivity to hot and cold temperatures (10%) and loose teeth (7%) being the most common complaints. Dental caries was present in 37%, and 13% had visible dental plaque on more than half of their teeth. Dental extractions were performed in 24% of patients, and 22% received dental restorations. Conclusion Children and adolescents scheduled for aHSCT face a significant burden of oral disease, with notable dental issues that must be addressed before transplantation. This study highlights the importance of pre-transplant dental evaluations in addressing remaining dental concerns and minimizing post-transplant complications.
- Open Access
- 18 September 2025
- Published by Wiley in Oral Diseases
- Vol. 32 (2) , 569-579
Patient‐Reported Oral Symptoms and Their Impact on Well‐Being After Haematopoietic Cell Transplantation
Objective: Oral complications may negatively influence outcomes of haematopoietic cell transplantation (HCT). A comprehensive view of oral symptoms and symptom burden post‐HCT is lacking. This study aimed to determine the prevalence, severity, and temporal relationships of oral symptoms and their impact on well‐being in the early post‐HCT phase. Effects of transplant type and conditioning intensity were evaluated. Methods: In this prospective multicentre observational study, adult HCT recipients were interviewed and completed questionnaires on oral symptoms and well‐being three times a week during hospitalisation early post‐HCT. Results: Of 194 patients, 177 (91.2%) reported oral symptoms. Dry mouth was the earliest and most common (80.9%) followed by oral pain (35.6%), thickening/swollen mucosa (33.0%), and taste changes (30.9%). Symptom frequency peaked on days 6 to 11 post‐HCT and caused significant burden: 59.3% experienced moderate to severe distress and 53.6% reported moderate to severe impact on well‐being. Symptom prevalence was highest among patients who received allogeneic HCT with MAC and those who underwent autologous HCT. Overall, MAC regimens were associated with earlier and more frequent symptoms, greater distress and higher impact on well‐being during days 0 to 11 post‐HCT compared to reduced/non‐myeloablative regimens. Conclusions: Oral symptoms are prevalent, burdensome and significantly impact well‐being early post‐HCT, underscoring the need for close monitoring and supportive oral care.
- 18 September 2025
- Published by Wiley in Oral Diseases
- Vol. 32 (2) , 569-579
Open AccessPatient‐Reported Oral Symptoms and Their Impact on Well‐Being After Haematopoietic Cell Transplantation
Objective: Oral complications may negatively influence outcomes of haematopoietic cell transplantation (HCT). A comprehensive view of oral symptoms and symptom burden post‐HCT is lacking. This study aimed to determine the prevalence, severity, and temporal relationships of oral symptoms and their impact on well‐being in the early post‐HCT phase. Effects of transplant type and conditioning intensity were evaluated. Methods: In this prospective multicentre observational study, adult HCT recipients were interviewed and completed questionnaires on oral symptoms and well‐being three times a week during hospitalisation early post‐HCT. Results: Of 194 patients, 177 (91.2%) reported oral symptoms. Dry mouth was the earliest and most common (80.9%) followed by oral pain (35.6%), thickening/swollen mucosa (33.0%), and taste changes (30.9%). Symptom frequency peaked on days 6 to 11 post‐HCT and caused significant burden: 59.3% experienced moderate to severe distress and 53.6% reported moderate to severe impact on well‐being. Symptom prevalence was highest among patients who received allogeneic HCT with MAC and those who underwent autologous HCT. Overall, MAC regimens were associated with earlier and more frequent symptoms, greater distress and higher impact on well‐being during days 0 to 11 post‐HCT compared to reduced/non‐myeloablative regimens. Conclusions: Oral symptoms are prevalent, burdensome and significantly impact well‐being early post‐HCT, underscoring the need for close monitoring and supportive oral care.
- Open Access
- 18 January 2024
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 30 (4) , 446.e1-446.e11
Subjective Oral Dryness following Hematopoietic Cell Transplantation: A Report from the Orastem Study
- 18 January 2024
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 30 (4) , 446.e1-446.e11
Open AccessSubjective Oral Dryness following Hematopoietic Cell Transplantation: A Report from the Orastem Study
- Open Access
- 16 November 2023
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 31 (12) , 1-10
Incidence, severity, and temporal development of oral complications in pediatric allogeneic hematopoietic stem cell transplant patients – a multicenter study
Purpose: Oral mucositis is a common complication for patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) and causes pain and difficulties in functions like eating and swallowing, resulting in lower quality of life and greater need of treatment with opioids and parenteral nutrition. This prospective multicenter study focused on pediatric recipients of HSCT in the neutropenic phase concerning oral complications, timing, severity, and patient experience. Methods: The cohort comprised 68 patients, median age 11.1 years (IQR 6.3) receiving allogeneic HSCT at three clinical sites. Medical records were retrieved for therapy regimens, concomitant medications, oral and dental history, and subjective oral complaints. Calibrated dentists conducted an oral and dental investigation before HSCT. After HSCT graft infusion, study personnel made bedside assessments and patients filled out a questionnaire once or twice a week until neutrophil engraftment. Results: We followed 63 patients through the neutropenic phase until engraftment. 50% developed oral mucositis of grades 2–4. Peak severity occurred at 8–11 days after stem cell infusion. Altogether, 87% had subjective oral complaints. The temporal distribution of adverse events is similar to the development of oral mucositis. The most bothersome symptoms were blisters and oral ulcerations, including mucositis; 40% reported severe pain and major impact on activities of daily living despite continuous use of opioids. Conclusion: This study highlights the burden of oral complications and their negative effect on the health and quality of life of HSCT recipients.
- 16 November 2023
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 31 (12) , 1-10
Open AccessIncidence, severity, and temporal development of oral complications in pediatric allogeneic hematopoietic stem cell transplant patients – a multicenter study
Purpose: Oral mucositis is a common complication for patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) and causes pain and difficulties in functions like eating and swallowing, resulting in lower quality of life and greater need of treatment with opioids and parenteral nutrition. This prospective multicenter study focused on pediatric recipients of HSCT in the neutropenic phase concerning oral complications, timing, severity, and patient experience. Methods: The cohort comprised 68 patients, median age 11.1 years (IQR 6.3) receiving allogeneic HSCT at three clinical sites. Medical records were retrieved for therapy regimens, concomitant medications, oral and dental history, and subjective oral complaints. Calibrated dentists conducted an oral and dental investigation before HSCT. After HSCT graft infusion, study personnel made bedside assessments and patients filled out a questionnaire once or twice a week until neutrophil engraftment. Results: We followed 63 patients through the neutropenic phase until engraftment. 50% developed oral mucositis of grades 2–4. Peak severity occurred at 8–11 days after stem cell infusion. Altogether, 87% had subjective oral complaints. The temporal distribution of adverse events is similar to the development of oral mucositis. The most bothersome symptoms were blisters and oral ulcerations, including mucositis; 40% reported severe pain and major impact on activities of daily living despite continuous use of opioids. Conclusion: This study highlights the burden of oral complications and their negative effect on the health and quality of life of HSCT recipients.
- Open Access
- 18 May 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (5) , e0285615
Oral health in patients scheduled for hematopoietic stem cell transplantation in the Orastem study
Despite advances in transplant medicine, prevalence of complications after hematopoietic stem cell transplantation (HSCT) remains high. The impact of pre-HSCT oral health factors on the incidence and severity of complications post-HSCT is poorly understood. The aim of this prospective, observational study was to analyze oral health in patients planned for HSCT. Patients ≥18 years requiring HSCT were included from five sites between 2011–2018. General health, oral findings and patient-reported symptoms were registered in 272 patients. Oral symptoms around disease onset were reported by 43 patients (15.9%) and 153 patients (58.8%) reported oral complications during previous chemotherapy. One third of patients experienced oral symptoms at the oral examination before conditioning regimen and HSCT. In total, 124 (46.1%) patients had dental caries, 63 (29.0%) had ≥one tooth with deep periodontal pockets, 147 (75.0%) had ≥one tooth with bleeding on probing. Apical periodontitis was observed in almost 1/4 and partially impacted teeth in 17 (6.3%) patients. Oral mucosal lesions were observed in 84 patients (30.9%). A total of 45 (17.4%) of 259 patients had at least one acute issue to be managed prior to HSCT. In conclusion, oral symptoms and manifestations of oral disease were prevalent in patients planned for HSCT. The extent of oral and acute dental diseases calls for general oral screening of patients pre-HSCT.
- 18 May 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (5) , e0285615
Open AccessOral health in patients scheduled for hematopoietic stem cell transplantation in the Orastem study
Despite advances in transplant medicine, prevalence of complications after hematopoietic stem cell transplantation (HSCT) remains high. The impact of pre-HSCT oral health factors on the incidence and severity of complications post-HSCT is poorly understood. The aim of this prospective, observational study was to analyze oral health in patients planned for HSCT. Patients ≥18 years requiring HSCT were included from five sites between 2011–2018. General health, oral findings and patient-reported symptoms were registered in 272 patients. Oral symptoms around disease onset were reported by 43 patients (15.9%) and 153 patients (58.8%) reported oral complications during previous chemotherapy. One third of patients experienced oral symptoms at the oral examination before conditioning regimen and HSCT. In total, 124 (46.1%) patients had dental caries, 63 (29.0%) had ≥one tooth with deep periodontal pockets, 147 (75.0%) had ≥one tooth with bleeding on probing. Apical periodontitis was observed in almost 1/4 and partially impacted teeth in 17 (6.3%) patients. Oral mucosal lesions were observed in 84 patients (30.9%). A total of 45 (17.4%) of 259 patients had at least one acute issue to be managed prior to HSCT. In conclusion, oral symptoms and manifestations of oral disease were prevalent in patients planned for HSCT. The extent of oral and acute dental diseases calls for general oral screening of patients pre-HSCT.
- Open Access
- 8 January 2021
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 56 (6) , 1381-1390
Significant salivary changes in relation to oral mucositis following autologous hematopoietic stem cell transplantation
The aim of this multicentre, longitudinal study was to determine salivary changes in relation to oral mucositis (OM) in multiple myeloma patients following high-dose melphalan and autologous hematopoietic stem cell transplantation (ASCT). Unstimulated and stimulated whole-mouth saliva samples (UWS and SWS) were collected before ASCT, 1×/wk during the hospitalisation phase, and 3 and 12 months post-ASCT. During the hospitalisation period OM was scored 3×/wk (WHO system). Flow rate, pH, total protein concentration (Nanodrop), albumin, lactoferrin, neutrophil defensin-1 (HNP1), total IgA and S100A8/A9 (ELISA) were determined. Mixed models were used to evaluate differences between ulcerative (u)OM (≥2 WHO, n = 20) and non-uOM (n = 31) groups. Until 18 days after ASCT, flow rate, pH, total IgA and HNP1 levels decreased in UWS and/or SWS, while log lactoferrin levels were significantly increased (UWS: p = 0.016 95% CI [0.36, 3.58], SWS: p < 0.001 95% CI [1.14, 3.29]). Twelve months post-ASCT, salivary protein levels were similar to baseline except for log total IgA, which was higher (UWS: p < 0.001 95% CI [0.49, 1.29], SWS: p < 0.001 95% CI [0.72, 1.45]). No differences between uOM and non-uOM groups were observed. Changes in salivary proteins indicated an inflammatory reaction in salivary glands coinciding with mucosal and systemic reactions in response to high-dose melphalan.
- 8 January 2021
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 56 (6) , 1381-1390
Open AccessSignificant salivary changes in relation to oral mucositis following autologous hematopoietic stem cell transplantation
The aim of this multicentre, longitudinal study was to determine salivary changes in relation to oral mucositis (OM) in multiple myeloma patients following high-dose melphalan and autologous hematopoietic stem cell transplantation (ASCT). Unstimulated and stimulated whole-mouth saliva samples (UWS and SWS) were collected before ASCT, 1×/wk during the hospitalisation phase, and 3 and 12 months post-ASCT. During the hospitalisation period OM was scored 3×/wk (WHO system). Flow rate, pH, total protein concentration (Nanodrop), albumin, lactoferrin, neutrophil defensin-1 (HNP1), total IgA and S100A8/A9 (ELISA) were determined. Mixed models were used to evaluate differences between ulcerative (u)OM (≥2 WHO, n = 20) and non-uOM (n = 31) groups. Until 18 days after ASCT, flow rate, pH, total IgA and HNP1 levels decreased in UWS and/or SWS, while log lactoferrin levels were significantly increased (UWS: p = 0.016 95% CI [0.36, 3.58], SWS: p < 0.001 95% CI [1.14, 3.29]). Twelve months post-ASCT, salivary protein levels were similar to baseline except for log total IgA, which was higher (UWS: p < 0.001 95% CI [0.49, 1.29], SWS: p < 0.001 95% CI [0.72, 1.45]). No differences between uOM and non-uOM groups were observed. Changes in salivary proteins indicated an inflammatory reaction in salivary glands coinciding with mucosal and systemic reactions in response to high-dose melphalan.
- Open Access
- 1 January 2020
- Published by Taylor & Francis in Journal of Oral Microbiology
- Vol. 12 (1) , 1761135
Lasting Gammaproteobacteria profile changes characterized hematological cancer patients who developed oral mucositis following conditioning therapy
Background: Oral mucositis (OM) is a common side effect of conditioning therapy implemented before hematopoietic stem cell transplantation (HSCT). The role of oral microbiome in OM is not fully elucidated. Objective: To determine oral microbiome profile changes post-conditioning in HSCT patients who developed moderate OM, or mild to no OM. Design: Patient groups were: Muc0-1 with OM-score = 0–1 (43 paired samples) and Muc2 with WHO OM-score = 2 (36 paired samples). Bacterial DNA was isolated from oral samples (saliva, swabs of buccal mucosa, tongue, and supragingival plaque) at pre-conditioning (T0), post-conditioning mucositis onset (TMuc), and one-year post-conditioning (TYear). 16S-rRNA gene next-generation sequencing was used to determine the relative abundance (RA) of >700 oral species. Alpha-diversity, beta-diversity and linear discriminant analyses (LDA) were performed Muc2 versus Muc0-1. Results: Muc2 oral microbiome alpha- and beta-diversity differed between T0 and TMuc. Muc2 alpha-diversity and Muc0-1 beta-diversity did not differ between T0 and TYear. T0 to TMuc LDA scores were significant in Muc2 for Gammaproteobacteria. For Muc2 patients, the average RA decreased for Haemophilus parainfluenza, a species known as mucosal surfaces protector, but increased for Escherichia-Shigella genera. Conclusions: Post-conditioning OM might contribute to long-term oral microbiome changes affecting Gammaproteobacteria, in HSCT patients.
- 1 January 2020
- Published by Taylor & Francis in Journal of Oral Microbiology
- Vol. 12 (1) , 1761135
Open AccessLasting Gammaproteobacteria profile changes characterized hematological cancer patients who developed oral mucositis following conditioning therapy
Background: Oral mucositis (OM) is a common side effect of conditioning therapy implemented before hematopoietic stem cell transplantation (HSCT). The role of oral microbiome in OM is not fully elucidated. Objective: To determine oral microbiome profile changes post-conditioning in HSCT patients who developed moderate OM, or mild to no OM. Design: Patient groups were: Muc0-1 with OM-score = 0–1 (43 paired samples) and Muc2 with WHO OM-score = 2 (36 paired samples). Bacterial DNA was isolated from oral samples (saliva, swabs of buccal mucosa, tongue, and supragingival plaque) at pre-conditioning (T0), post-conditioning mucositis onset (TMuc), and one-year post-conditioning (TYear). 16S-rRNA gene next-generation sequencing was used to determine the relative abundance (RA) of >700 oral species. Alpha-diversity, beta-diversity and linear discriminant analyses (LDA) were performed Muc2 versus Muc0-1. Results: Muc2 oral microbiome alpha- and beta-diversity differed between T0 and TMuc. Muc2 alpha-diversity and Muc0-1 beta-diversity did not differ between T0 and TYear. T0 to TMuc LDA scores were significant in Muc2 for Gammaproteobacteria. For Muc2 patients, the average RA decreased for Haemophilus parainfluenza, a species known as mucosal surfaces protector, but increased for Escherichia-Shigella genera. Conclusions: Post-conditioning OM might contribute to long-term oral microbiome changes affecting Gammaproteobacteria, in HSCT patients.